Multicenter study on clinicopathological features, molecular genetic abnormalities, treatment and prognosis of gastrointestinal malignant lymphomas

Multicenter study on clinicopathological features, molecular genetic abnormalities, treatment and prognosis of gastrointestinal malignant lymphomas - Multicenter study on clinicopathological features, molecular genetic abnormalities, treatment and prognosis of gastrointestinal malignant lymphomas

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000027701

Enrollment

700

Registered

2017-06-09

Start date

2017-03-29

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Gastrointestinal malignant lymphoma

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients with gastrointestinal malignant lymphoma diagnosed at Kyushu university hospital and collaborative research facilities from 1970 to 2023.

Exclusion criteria

Exclusion criteria: Patients who reject this research.

Design outcomes

Primary

Measure	Time frame
Correlation between treatment and prognosis in gastrointestinal malignant lymphoma	—

Secondary

Measure	Time frame
Correlation among clinicopathological features, chromosomal abnormalities, expression of miRNA or mRNA, prognosis, and therapeutic response of gastrointestinal malignant lymphoma	—

Countries

Japan

Contacts

Public ContactYuichi Matsuno

Kyushu University Department of Medicine and Clinical Science, Graduate School of Medical Sciences

ymatsuno@intmed2.med.kyushu-u.ac.jp+81(0)92-642-5261

Outcome results